Published in Schweiz Med Wochenschr on September 02, 1978
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Erythema of the proximal nailfold in HIV-infected patients. J Am Acad Dermatol (1996) 1.59
Natural history of the Naegeli-Franceschetti-Jadassohn syndrome and further delineation of its clinical manifestations. J Am Acad Dermatol (1993) 1.52
[Telemedicine: perspectives and multidisciplinary approach]. Schweiz Med Wochenschr (2000) 1.42
[Ross syndrome]. Hautarzt (1992) 1.39
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance. A review. Dermatologica (1981) 1.20
Identification of Neisseria gonorrhoeae in the routine venerelogical laboratory: Comparative study of coagglutination, direct immunofluorescence, and sugar fermentation reaction. Br J Vener Dis (1980) 1.13
[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13
Atrophoderma of Pasini and Pierini. Clinical and histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four patients. J Am Acad Dermatol (1994) 1.12
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11
Which Neisseria? Br J Vener Dis (1978) 1.05
Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology (2004) 1.04
Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection (2002) 0.97
Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94
Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94
Pachydermodactyly: reflecting obsessive-compulsive behavior? Arch Dermatol (1994) 0.92
Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91
Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol (1998) 0.90
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
The petrified ear. Dermatology (1994) 0.87
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86
beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Invest Dermatol (2000) 0.86
Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression. J Invest Dermatol (2003) 0.86
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86
Characterization of mu-opiate receptor in human epidermis and keratinocytes. Ann N Y Acad Sci (1999) 0.85
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer (1984) 0.85
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol (1986) 0.84
The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol (1970) 0.84
[Pattern of epithelium formation in human and guinea-pig skin (author's transl)]. Dermatologica (1976) 0.83
Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83
Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res (1970) 0.83
T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica (1984) 0.82
Identification of lymphocyte subpopulations by simultaneous E-rosette formation and unspecific acid esterase staining. Experientia (1978) 0.82
[The differential diagnosis of indolent ulcers upon return from the Tropics: frambesia]. Schweiz Med Wochenschr (1984) 0.82
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol (1982) 0.82
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82
[Epidemiology of skin diseases in HIV-infected patients: a prospective cohort study]. Praxis (Bern 1994) (1996) 0.82
[Morphaea profunda]. Hautarzt (1990) 0.81
Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81
Antibiotic sensitivity of gonococcal strains isolated from patients in Basel and environs. Dermatologica (1979) 0.81
[Immunosuppression: a paraneoplastic syndrome]. Schweiz Med Wochenschr (1971) 0.81
Suppressed colony formation of peripheral blood lymphocytes in a patient with somatostatinoma. Clin Immunol Immunopathol (1986) 0.80
[Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr (1985) 0.80
[The IF diagnosis of gonorrhea]. Dermatologica (1973) 0.80
Mitomycin-induced haemolysis and renal failure. Lancet (1980) 0.80
Localized scleroderma associated with Borrelia burgdorferi infection. Clinical, histologic, and immunohistochemical observations. J Am Acad Dermatol (1993) 0.79
Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res (1982) 0.79
Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J Clin Lab Immunol (1985) 0.79
In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma. Carcinogenesis (1995) 0.79
[Prognosis of currently available methods of gonorrhea detection]. Schweiz Med Wochenschr (1974) 0.79
Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79
Aminoglutethimide. Penetration of the blood brain barrier. Invest New Drugs (1986) 0.79
[Metastasizing adenocarcinoma from an unknown primary tumor]. Dtsch Med Wochenschr (1984) 0.79
Differential expression of endogenous sugar-binding proteins (lectins) in murine tumor model systems with metastatic capacity. Int J Cancer (1987) 0.78
Delayed-type hypersensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests. Contact Dermatitis (1996) 0.78
Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases. J Am Acad Dermatol (1993) 0.78
Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients? Dermatology (1999) 0.78
Chromatofocusing combined with the ELISA technique. A sensitive method for the analysis of immune complexes. J Immunol Methods (1983) 0.78
[Bromocriptine in chemotherapy-resistant, metastatic breast cancer. Results of the GO-MC-BROMO 2/82 AIO Study]. Onkologie (1988) 0.78
[Thrombocytosis in malignant tumors]. Schweiz Med Wochenschr (1973) 0.78
Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial. Onkologie (1988) 0.78
[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors]. Schweiz Med Wochenschr (1972) 0.78
Oral hairy leukoplakia in a HIV-negative renal transplant patient: a marker for immunosuppression? Dermatologica (1988) 0.77
[Chronic granulocytopenia as a main symptom of T gamma-lymphocytosis]. Dtsch Med Wochenschr (1989) 0.77
[Dermatological entomology. The practical medical importance of mites and insects in Switzerland and its adjoining regions. 34. Diagnosis and differential diagnosis]. Schweiz Rundsch Med Prax (1982) 0.77
Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer. Clin Immunol Immunopathol (1988) 0.77
[Demodex folliculorum: aetiopathogenesis and therapy of rosacea and perioral dermatitis (author's transl)]. Dermatologica (1981) 0.77
Effect of ether lipids on mouse granulocyte-macrophage progenitor cells. Cancer Chemother Pharmacol (1989) 0.77
Carbohydrate-binding proteins of tumor lines with different growth properties. II. Changes in their pattern in clones of transformed rat fibroblasts of differing metastatic potential. Cell Tissue Res (1986) 0.77
[Oral pemphigus vulgaris. Successful treatment with minocycline and nicotinamide]. Hautarzt (2002) 0.77
[Mucin-like carcinoma-associated antigen: sensitivity and specificity in metastatic breast cancer]. Onkologie (1990) 0.77
[Treatment of scabies with special consideration of the approach in infancy, pregnancy and while nursing]. Hautarzt (2000) 0.77
Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years. Transplant Proc (1994) 0.77
Human interferon therapy for herpes zoster in adults. Scand J Infect Dis (1975) 0.77
Biological and biochemical characterization of a somatostatin-producing human carcinoma established by heterotransplantation. Cancer Res (1985) 0.77
[Prophylaxis and therapy of cytostatic-induced skin necrosis]. Onkologie (1980) 0.77
Adverse skin reactions to nicotine in a transdermal therapeutic system. Contact Dermatitis (1991) 0.76
Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie (1990) 0.76
Erythema chronicum migrans: evidence for cellular immune reaction in the skin lesion. Dermatologica (1987) 0.76
In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Br J Dermatol (1996) 0.76
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Onkologie (1987) 0.76
Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia. Eur J Haematol (1990) 0.76
Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies. Eur J Cancer Clin Oncol (1989) 0.76
Malignant lymphoma in four of five siblings. Int J Cancer (1978) 0.76
[Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron]. Onkologie (1990) 0.75
[Human infestation by Sarcoptes scabiei var. bovis (cattle itch mite)]. Hautarzt (1979) 0.75
Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies. Mol Biother (1988) 0.75
Carbohydrate-binding proteins of tumor lines with different growth properties. I. Differences in their pattern for three clones of rat fibroblasts transformed with a myeloproliferative sarcoma virus. Cell Tissue Res (1985) 0.75
[Gaucher disease and pregnancy]. Z Geburtshilfe Perinatol (1989) 0.75
Cancer treatments. Nature (1991) 0.75
[The cancer patient between academic medicine and alternative medicine--therapeutic concepts]. Arch Gynecol Obstet (1995) 0.75
Acrodermatitis chronica atrophicans involving the face. Evidence for Borrelia burgdorferi infection confirmed by DNA amplification. Dermatology (1994) 0.75
Vindesine. A clinical trial with special reference to neurological side effects. Cancer Chemother Pharmacol (1979) 0.75
[Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy]. Schweiz Med Wochenschr (1979) 0.75
[Familial Hodgkin's disease: a case report and review of the literature]. Onkologie (1979) 0.75
[Prevention of infection in agranulocytosis: 1st experiences with patient isolation and whole body decontamination. Preliminary report]. Schweiz Med Wochenschr (1974) 0.75
[Staging of Hodgkin's disease by laparotomy: therapeutic consequences]. Chirurg (1979) 0.75